Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
25 feb 2015 - 13:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to present at European Life Sciences Conferences
Bericht
Probiodrug to present at European Life Sciences Conferences
HALLE/SAALE, Germany, 25 February 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Probiodrug's CEO and co-founder, Dr Konrad Glund, is scheduled to present at the following events:
Datum laatste update: 28 juli 2024